![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/127 | (2006.01) |
C07C 211/00 | (2006.01) | ||
A61K 31/20 | (2006.01) | ||
C12N 5/00 | (2006.01) | ||
A61K 48/00 | (2006.01) | ||
A61K 47/50 | (2017.01) | ||
A61P 9/00 | (2006.01) | ||
A61P 25/28 | (2006.01) |
(11) | Number of the document | 3431076 |
(13) | Kind of document | T |
(96) | European patent application number | 18174274.3 |
Date of filing the European patent application | 2010-06-10 | |
(97) | Date of publication of the European application | 2019-01-23 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
(46) | Date of publication of the claims translation | 2021-10-25 |
(30) | Number | Date | Country code |
18580009 P | 2009-06-10 | US | |
24483409 P | 2009-09-22 | US |
(72) |
AKINC, Akin , US
DORKIN, Joseph, R. , US
QIN, Xiaojun , US
CANTLEY, William , US
MANOHARAN, Muthiah , US
RAJEEV, Kallanthottathil, G. , US
NARAYANANNAIR, Jayaprakash, K. , US
JAYARAMAN, Muthusamy , US
CHEN, Jianxin , US
ANSELL, Steven , US
|
(73) |
Arbutus Biopharma Corporation ,
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8,
CA
|
(74) |
Gediminas PRANEVIČIUS,
Advokatų profesinė bendrija IP FORMA, Užupio g. 30, LT-01203 Vilnius,
LT
|
(54) | Patobulinta lipidinė kompozicija |
IMPROVED LIPID FORMULATION |
Payment date | Validity (years) | Amount | |
2025-04-24 | 16 | 347.00 EUR |
2026-06-10 |